Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytarabine syndrome risk factor analysis in children with acute lymphoblastic leukemia
ChiCTR2500098713Phase 4Recruiting
- Sponsor
- Shenzhen Children's Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cytarabine in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Shenzhen Children's Hospital. Primary endpoints: White blood cell count, Neutrophil count and 3 more. Started Mar 2025; status: recruiting.
02
Drugs
cytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on ChiCTR2500098713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098713.